Found 9 matching trials
Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects PHASE3 The purpose of Study GS-01-934 was to assess the efficacy and safety of two...
Show More Location
AIDS Healthcare Foundation Research
Learn More & Join Trial
Early HIV Therapy in Patients With High CD4 Cell Counts NA A study of antiretroviral therapy (ART) initiation under a "streamlined mod...
Show More Location
Bwizibwera Level IV Health Center
Learn More & Join Trial
Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r) PHASE3 The primary purpose of this study is to assess the rate of early discontinu...
Show More Location
Multiple Locations
Learn More & Join Trial
ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens PHASE4 In treatment naïve HIV infected subjects, combination antiretroviral therap...
Show More Location
Multiple Locations
Learn More & Join Trial
ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial PHASE4 This study aims to investigate whether patients switching their backbone fr...
Show More Learn More & Join Trial
Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients. PHASE1 This study consists of 2 parts, Part A and Part B. Part A, the Phase 1 drug...
Show More Location
Fundacion de Investigacion de Diego
Learn More & Join Trial
Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS PHASE3 This study was done to compare the safety and efficacy of three combination...
Show More Location
Instituto de Pesquisa Clinica Evandro Chagas (12101)
Learn More & Join Trial
Safety and Efficacy of Switching From Regimens of ABC/3TC + a 3rd Agent to E/C/F/TAF Fixed-Dose Combination (FDC) in Virologically-Suppressed HIV 1 Infected Adults PHASE3 The primary objective of this study is to evaluate the efficacy of switchin...
Show More Location
Spectrum Medical Group
Learn More & Join Trial
Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years PHASE3 The primary objective of this study is to evaluate the safety of elvitegrav...
Show More Location
CHU Saint-Pierre University Hospital
Learn More & Join Trial